Planning a Green field / Brown field projects
Launching a new Greenfield pharmaceutical manufacturing facility or revamping an existing Brownfield site is one of the most capital-intensive and regulatory-complex undertakings a life sciences organization can face—where a single oversight in design, zoning, or compliance strategy can cost millions in delays and rework. Our Planning a Green field / Brown field projects service provides end-to-end strategic and technical project management, guiding you from conceptual master planning and regulatory gap analysis through to operational handover and inspection-ready start-up. For Greenfield projects, we partner with your engineering and architecture teams to embed GMP principles into the very blueprints—optimizing cleanroom zoning, utility loops (purified water/WFI), and material/personnel flows to meet global FDA, EMA, and WHO standards from day one, while simultaneously architecting your QMS, documentation hierarchy, and validation master plan in parallel with construction milestones. For Brownfield projects, we conduct a forensic-level due diligence and gap assessment of existing facilities, equipment, and quality systems to identify hidden remediation liabilities, data integrity vulnerabilities, and compliance gaps that must be addressed before expansion or technology transfer, ensuring your investment delivers a fully compliant, scalable asset rather than a costly regulatory headache.
Crucially, we provide hands on resourcing support across the entire lifecycle—from hyper-specialized technical expertise and SOP development to facility qualification, process/CSV/method validation, and comprehensive staff training—culminating in a rigorous Facility Readiness Review that leaves your new or upgraded site audit-ready and poised for rapid regulatory approval and commercial production. With our integrated approach, we de-risk your capital project, compress your time-to-market, and transform your physical and quality infrastructure into a competitive, future-ready strategic asset.
Contact us now if you are looking for:
- Facility/Site Start-Up Resources
- QMS Development & Implementation
- Documentation & SOP Development
- Process Validation
- Computer System Validation
- Method Validation
- Facility Readiness Reviews
- GMP Audits (for brownfield gap assessments and greenfield design benchmarking)
- Manufacturing Quality & Aseptic Operations (critical for facility layout and workflow)
- Due diligence for purchase / acquisitions (highly relevant for brownfield site evaluations)
FAQs
A Greenfield project involves designing and constructing a new pharmaceutical facility from the ground up, while a Brownfield project focuses on expanding, upgrading, modernizing, or repurposing an existing facility. Both require careful planning to align operational goals with GMP and regulatory expectations.
Integrating GMP principles during project planning helps optimize facility layout, cleanroom design, utility systems, material and personnel flow, contamination control, and operational efficiency. Early planning can reduce costly redesigns, qualification delays, and compliance challenges later in the project lifecycle.
Project planning may include feasibility assessments, facility layout reviews, cleanroom zoning, utility planning, regulatory gap assessments, quality system design, SOP development, validation strategy, qualification planning, staffing support, training, and operational readiness activities.
A Brownfield assessment evaluates existing facilities, equipment, utilities, documentation, quality systems, and operational controls to identify compliance gaps, infrastructure limitations, remediation requirements, and potential risks that could impact future expansion, technology transfer, or regulatory inspections.
Quality systems, validation planning, and documentation strategies should ideally begin during the early design phase. Aligning QMS development, qualification activities, and validation requirements with construction and commissioning milestones helps support smoother project execution and operational readiness.
A Facility Readiness Review is a structured evaluation performed before commercial operations or regulatory inspections. It assesses facilities, utilities, documentation, validation status, training records, quality systems, and operational controls to determine preparedness for manufacturing activities and external audits.
Well-planned projects can provide scalable infrastructure, optimized workflows, flexible manufacturing capacity, improved compliance controls, and enhanced operational efficiency. These capabilities help organizations accommodate future product pipelines, market expansion strategies, and evolving regulatory requirements.
Common challenges include inadequate facility design, utility capacity constraints, poor workflow planning, qualification delays, documentation gaps, validation deficiencies, change management issues, project coordination challenges, and evolving regulatory expectations during implementation.
Yes. Comprehensive project planning can incorporate quality systems, validation programs, training initiatives, documentation controls, facility qualification, and readiness assessments designed to support a smoother transition into routine operations and future regulatory inspections.
External specialists can provide independent technical oversight, regulatory perspective, project management support, validation expertise, quality system guidance, and operational readiness planning. Their experience can help organizations identify risks early and improve project execution outcomes.